Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ArQule, Inc.    ARQL   US04269E1073

ARQULE, INC.

 (ARQL)

1
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/16/2013 05/17/2013 05/20/2013 05/21/2013 05/22/2013 Date
2.78(c) 2.8(c) 2.78(c) 2.78(c) 2.71(c) Last
179 083 179 184 178 836 208 131 169 232 Volume
-2.11% +0.72% -0.71% 0.00% -2.52% Change
More quotes
Company
Surperformance© rating of ArQule, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ARQULE, INC.
Duration : Period :
ArQule, Inc. Technical Analysis Chart | ARQL | US04269E1073 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 17,2 M
EBIT 2013 -29,4 M
Net income 2013 -28,9 M
Finance 2013 88,6 M
Yield 2013 -
Sales 2014 17,6 M
EBIT 2014 -33,6 M
Net income 2014 -32,7 M
Finance 2014 44,0 M
Yield 2014 -
PER 2013 -
PER 2014
EV / Sales 2013 4,97x
EV / Sales 2014 7,37x
Capitalization 174 M
More Financials
Latest news on ARQULE, INC.
05/08 ARQULE, INC.: ArQule Reports First Quarter 2013 Financial Results
05/01 ARQULE, INC.: ArQule to Report First Quarter 2013 Financial Results on May 8, 2..
04/23 ARQULE, INC.: to Present at Needham 12th Annual Healthcare Conference
04/09 ARQULE, INC.: ArQule's Novel AKT Pathway Inhibitor, ARQ 092, Demonstrates Safet..
04/01 ARQULE, INC.: ArQule Regains Worldwide Rights to AKT Program
03/14 ARQULE, INC.: ArQule Reports Fiscal 2012 Year End and Fourth Quarter Results
03/07 ARQULE, INC.: ArQule to Report Fiscal 2012 Financial Results on March 14, 2013
02/27 ARQULE, INC.: to Present at Cowen and Company 33rd Annual Health Care Conferenc..
02/19 ARQULE, INC.: to Present at RBC Capital Markets Global Healthcare Conference
02/07 ARQULE, INC.: to Present at Leerink Swann Global Healthcare Conference
01/31 ARQULE, INC.: Daiichi Sankyo and ArQule Enroll First Hepatocellular Carcinoma P..
01/11 ARQULE, INC.: Daiichi Sankyo and ArQule Announce Top-Line Results of Phase 2 Tr..
More news
Forum ARQULE, INC.
Advertisement
Income Statement Evolution
ArQule, Inc. : Income Statement Evolution
More Financials
EPS Revisions
ArQule, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.